Preprint examines pathogenic impact of ABCA4 missense variants in a structurally uncharacterised domain
Researchers have assessed the functional effects of missense variants of uncertain significance in the ECD1 region of ABCA4, which is implicated in Stargardt disease and other inherited retinal conditions.
A preprint deposited on bioRxiv reports new analysis of missense variants of uncertain significance (VUS) in the ABCA4 gene, focusing on the first extracellular domain (ECD1) — a region where limited structural data and inconsistent computational predictions have historically made it difficult to interpret whether a given variant is disease-causing.
Pathogenic variants in ABCA4 are the principal cause of Stargardt disease (STGD1), the most common inherited macular dystrophy, as well as several related inherited retinal conditions. Many patients carry at least one ABCA4 variant whose pathogenicity cannot be conclusively established, leaving families and clinicians in diagnostic uncertainty. The ECD1 region contains a disproportionate number of these unresolved variants.
The preprint authors describe structural and functional analyses aimed at improving interpretation of VUS in this region. The work has not yet been peer-reviewed. If the approach is validated, it could inform the reclassification of variants that currently impede confirmed diagnoses in patients with Stargardt disease or related phenotypes — a matter of direct relevance to genetic counselling practice, and to researchers working on inherited retinal diseases and variant-effect modelling.
Plain-language version
For patients, families, and general readers. Educational only — not medical advice.
Stargardt disease is an inherited condition that causes progressive loss of central vision. It is caused by faults in a gene called ABCA4. Some people with Stargardt-like symptoms have a change in ABCA4 that scientists cannot yet say for certain is harmful — these are called variants of uncertain significance, or VUS. A new research study (not yet formally reviewed by other scientists) has looked at a part of the ABCA4 protein that has been difficult to study until now, and has tried to work out which changes in that region are likely to cause disease. The aim is to reduce the number of people left without a clear genetic answer. This research is at an early stage and has not yet gone through peer review. This is an educational summary, not medical advice. If anything here raises questions for you, please speak with your GP or a clinical professional.
Sources
Read the original reporting — these are the public sources this summary draws from.
-
Primary sourcePreprint bioRxiv (Cold Spring Harbor Laboratory) · 2026-07-01Pathogenic impact of ABCA4 missense variants in the structurally uncharacterized ECD1 region: implications for Stargardt disease.